IONIS PHARMACEUTICALS INC IONS
- TRYNGOLZA — Familial Chylomicronemia Syndrome Approved
- TRYNGOLZA — Severe Hypertriglyceridemia Approved
- WAYLIVRA — Familial Chylomicronemia Syndrome Phase 3
- WAYLIVRA — Familial Partial Lipodystrophy Phase 2
apoC-III (1 companies · 4 programs)
Companies with an active program directed at apoC-III.